These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8330476)

  • 21. [Measles in Poland in 2002].
    Czarkowski MP; Kondej B
    Przegl Epidemiol; 2004; 58(1):21-7. PubMed ID: 15218638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of nationwide measles vaccination campaign among children aged 9 months to 14 years, Zimbabwe, 1998-2001.
    Munyoro MN; Kufa E; Biellik R; Pazvakavambwa IE; Cairns KL
    J Infect Dis; 2003 May; 187 Suppl 1():S91-6. PubMed ID: 12721898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Widespread outbreaks of measles in rural Uttar Pradesh, India, 1996: high risk areas and groups.
    Singh J; Kumar A; Rai RN; Khare S; Jain DC; Bhatia R; Datta KK
    Indian Pediatr; 1999 Mar; 36(3):249-56. PubMed ID: 10713838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pattern of susceptibility to measles in Italy. Serological Study Group.
    Salmaso S; Gabutti G; Rota MC; Giordano C; Penna C; Mandolini D; Crovari P
    Bull World Health Organ; 2000; 78(8):950-5. PubMed ID: 10994277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Edmonston-Zagreb strain of measles vaccine: epidemiologic evaluation in Yugoslavia.
    Ikić DM
    Rev Infect Dis; 1983; 5(3):558-63. PubMed ID: 6879014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles outbreak in Qassim, Saudi Arabia 2007: epidemiology and evaluation of outbreak response.
    Jahan S; Al Saigul AM; Abu Baker MA; Alataya AO; Hamed SA
    J Public Health (Oxf); 2008 Dec; 30(4):384-90. PubMed ID: 18716046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outbreak of measles in a highly vaccinated secondary school population.
    Sutcliffe PA; Rea E
    CMAJ; 1996 Nov; 155(10):1407-13. PubMed ID: 8943928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
    Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H
    Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles epidemiology and outbreak response immunization in a rural community in Peru.
    Sniadack DH; Moscoso B; Aguilar R; Heath J; Bellini W; Chiu MC
    Bull World Health Organ; 1999; 77(7):545-52. PubMed ID: 10444877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
    Miller E; Waight P; Gay N; Ramsay M; Vurdien J; Morgan-Capner P; Hesketh L; Brown D; Tookey P; Peckham C
    Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R26-32. PubMed ID: 9046126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Measles outbreaks in the Bern canton].
    Maurer AM; Mühlemann K
    Schweiz Med Wochenschr; 1998 Feb; 128(9):317-22. PubMed ID: 9544458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of a mass measles campaign in central Afghanistan, December 2001 to May 2002.
    Dadgar N; Ansari A; Naleo T; Brennan M; Salama P; Sadozai N; Golaz A; Lievano F; Jafari H; Mubarak M; Hoekstra E; Paganini A; Feroz F
    J Infect Dis; 2003 May; 187 Suppl 1():S186-90. PubMed ID: 12721912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interruption of indigenous measles transmission in Bolivia since October 2000.
    Quiroga R; Barrezueta O; Venczel L; Halkyer P; Gil F; Machicao E; Landaverde M; Quiñonez A; Izurieta H
    J Infect Dis; 2003 May; 187 Suppl 1():S121-6. PubMed ID: 12721902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A measles epidemic controlled by immunisation.
    Mansoor O; Blakely T; Baker M; Tobias M; Bloomfield A
    N Z Med J; 1998 Dec; 111(1079):467-71. PubMed ID: 9972200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Australian Measles Control Campaign, 1998.
    Turnbull FM; Burgess MA; McIntyre PB; Lambert SB; Gilbert GL; Gidding HF; Escott RG; Achat HM; Hull BP; Wang H; Sam GA; Mead CL
    Bull World Health Organ; 2001; 79(9):882-8. PubMed ID: 11584738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measles epidemiology and elimination strategies in Turkey.
    Güriş D; Bayazit Y; Ozdemirer U; Buyurgan V; Yalniz C; Toprak I; Aycan S
    J Infect Dis; 2003 May; 187 Suppl 1():S230-4. PubMed ID: 12721918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.